Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Congenital insensitivity to pain with anhidrosis (HSAN IV; MONDO:0009746) is an autosomal recessive neurodevelopmental disorder caused by biallelic loss-of-function mutations in the NTRK1 gene (HGNC:8031), which encodes the high-affinity receptor TrkA for nerve growth factor. Affected individuals exhibit absence of pain and temperature sensation, self-mutilation, anhidrosis, and variable intellectual disability.
Extensive genetic evidence from multiple cohorts supports a definitive association. Over 23 unrelated families [PMID:10982191] and seven additional pedigrees [PMID:10330344] have been reported with cosegregation of biallelic NTRK1 variants, including segregation in at least 19 affected relatives [PMID:10982191].
Variants span missense substitutions, frameshifts, nonsense, and splice-site mutations, predominantly clustering in the tyrosine kinase domain. A recurrent variant, c.2303C>T (p.Pro768Leu), has been observed in multiple ethnicities with milder phenotypes, while canonical splice mutations such as c.851-33T>A underlie founder haplotypes in Asian populations.
Functional studies uniformly demonstrate loss of TrkA activity. Autophosphorylation assays of mutant receptors reveal abrogated NGF-stimulated kinase activation [PMID:11159935], and misfolding/aggregation defects have been shown to disrupt autophagic flux in neuronal models [PMID:27551041]. PC12 differentiation assays confirm the inability of mutant TrkA to support NGF-dependent survival and neurite outgrowth.
No conflicting evidence has been reported; all pathogenic variants result in loss of NGF–TrkA signaling concordant with the human phenotype. The collective genetic and experimental data meet ClinGen definitive criteria for gene–disease validity.
Key take-home: Clinical testing for NTRK1 variants enables early diagnosis of HSAN IV, guiding management of temperature regulation and injury prevention.
Gene–Disease AssociationDefinitiveOver 23 unrelated families [PMID:10982191], segregation in 19 affected relatives [PMID:10982191], and consistent autosomal recessive occurrence Genetic EvidenceStrongBiallelic NTRK1 variants in >30 probands across multiple families with segregation in relatives Functional EvidenceStrongIn vitro assays show loss of TrkA autophosphorylation [PMID:11159935] and misfolding/aggregation disrupting autophagy [PMID:27551041] |